ASX:IHL

Stock Analysis Report

Impression Healthcare

Executive Summary

Impression Healthcare Limited, a healthcare company, manufactures and distributes professionally made home-impression custom-fit dental products.


Snowflake Analysis

Weak fundamentals or lack of information.

Share Price & News

How has Impression Healthcare's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: IHL's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-13.3%

IHL

-12.2%

AU Medical Equipment

-7.1%

AU Market


1 Year Return

173.7%

IHL

30.4%

AU Medical Equipment

6.7%

AU Market

Return vs Industry: IHL exceeded the Australian Medical Equipment industry which returned 30.4% over the past year.

Return vs Market: IHL exceeded the Australian Market which returned 6.7% over the past year.


Shareholder returns

IHLIndustryMarket
7 Day-13.3%-12.2%-7.1%
30 Day-22.4%-9.3%-5.3%
90 Day-21.2%-4.9%-3.2%
1 Year173.7%173.7%32.6%30.4%11.3%6.7%
3 Year-12.2%-20.0%60.9%53.6%28.2%11.2%
5 Yearn/a102.4%86.5%40.9%9.2%

Price Volatility Vs. Market

How volatile is Impression Healthcare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Impression Healthcare undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Impression Healthcare is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Impression Healthcare has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of IHL’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Impression Healthcare regulatory filings.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Impression Healthcare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

17.3%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Impression Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Impression Healthcare performed over the past 5 years?

7.8%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: IHL is currently unprofitable.

Growing Profit Margin: IHL is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if IHL's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare IHL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IHL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (14.7%).


Return on Equity

High ROE: IHL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Impression Healthcare's financial position?


Financial Position Analysis

Short Term Liabilities: IHL has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: IHL has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: IHL has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: IHL's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet

Inventory Level: IHL has a high level of physical assets or inventory.

Debt Coverage by Assets: IHL has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IHL has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: IHL has less than a year of cash runway if free cash flow continues to reduce at historical rates of -18% each year


Next Steps

Dividend

What is Impression Healthcare's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.5%markettop25%5.8%industryaverage1.4%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate IHL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate IHL's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if IHL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IHL's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IHL's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average management tenure


CEO

Joel Latham 0

1.7yrs

Tenure

AU$204,473

Compensation

Mr. Joel Latham has been Chief Executive Officer at Impression Healthcare Ltd. since June 29, 2018 and has been its Managing Director since July 24, 2019. Mr. Latham has worked as the General Manager of Im ...


CEO Compensation Analysis

Compensation vs Market: Joel's total compensation ($USD134.52K) is below average for companies of similar size in the Australian market ($USD252.03K).

Compensation vs Earnings: Joel's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Joel Latham
MD, CEO & Director1.7yrsAU$204.47k1.67% A$623.8k
Alistair Blake
Chief Technical Officer0yrsAU$228.02k2.97% A$1.1m
Sud Agarwal
Chief Medical Officer & Non-Executive Director0.6yrsno datano data
John Michailidis
Chief Executive Officer of IncannexTM0.3yrsno datano data
Glenn Fowles
Company Secretary2.2yrsno data0.56% A$208.0k

1.7yrs

Average Tenure

Experienced Management: IHL's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Joel Latham
MD, CEO & Director1.7yrsAU$204.47k1.67% A$623.8k
Sud Agarwal
Chief Medical Officer & Non-Executive Director0.6yrsno datano data
Troy Valentine
Non-Executive Chairman2.2yrsAU$36.30k1.21% A$452.7k
Peter Widdows
Non-Executive Director1.9yrsAU$36.30k1.71% A$638.7k
Rondhir Jithoo
Member of Medical Advisory Board0.4yrsno datano data
Simon Hinckfuss
Member of Medical Advisory Board0.4yrsno datano data
Michael Stubbs
Member of Medical Advisory Board0.4yrsno datano data
David Cunnington
Member of Medical Advisory Board0.4yrsno datano data

0.5yrs

Average Tenure

Experienced Board: IHL's board of directors are not considered experienced ( 0.5 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 96.3%.


Top Shareholders

Company Information

Impression Healthcare Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Impression Healthcare Limited
  • Ticker: IHL
  • Exchange: ASX
  • Founded:
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: AU$37.306m
  • Shares outstanding: 717.42m
  • Website: https://impression.healthcare

Location

  • Impression Healthcare Limited
  • 13 Central Avenue
  • Moorabbin
  • Victoria
  • 3189
  • Australia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IHLASX (Australian Securities Exchange)YesOrdinary SharesAUAUDOct 2016
IQIDB (Deutsche Boerse AG)YesOrdinary SharesDEEUROct 2016
IHLCHIA (Chi-X Australia)YesOrdinary SharesAUAUDOct 2016

Biography

Impression Healthcare Limited, a healthcare company, manufactures and distributes professionally made home-impression custom-fit dental products. The company offers custom-fitted sports mouth guards under the Gameday Mouthguards brand; and Instant Teeth Whitening at-home custom teeth whitening kits. It also provides The Knight Guard, a night plate for people that grind their teeth at night; and The Sleep Guardian, a custom mandibular advancement anti-snoring device. In addition, the company offers CBD oil products under the Incannex brand. Impression Healthcare Limited has a medicinal cannabis research collaboration with Cannvalate Pty Ltd and the Swinburne University of Technology to develop cannabis products for the treatment of sleep apnoea, concussion and traumatic brain disease, gum disease, and temporomandibular joint disorder. The company also has a license agreement with Resolution Chemicals Limited to support the production, registration, and commercialization of generic Dronabinol capsules. Impression Healthcare Limited is headquartered in Moorabbin, Australia. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/02/28 10:49
End of Day Share Price2020/02/28 00:00
Earnings2019/06/30
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.